机译:Inflammatory biomarkers predict outcomes of patients with radioactive iodine refractory thyroid cancer treated with sorafenib
Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center;
Department of Internal Medicine, Biomedical Research Institute,Pusan National University Hospital;
Department of Endocrinology,Dongnam Institute of Radiological and Medical Sciences Cancer CenterDivision of Endocrinology and Metabolism, Department of Internal Medicine, Severance HospitalDivision of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary’s;
Sorafenib; Thyroid cancer; Inflammatory biomarker; Lymphocyte;